Free Access
Med Sci (Paris)
Volume 20, Number 12, Décembre 2004
Page(s) 1096 - 1099
Section M/S revues
Published online 15 December 2004
  1. Jansen PL. From classic bile physiology to cloned transporters. Semin Liver Dis 2000; 20 : 245–50. [Google Scholar]
  2. Karpen SJ. Nuclear receptor regulation of hepatic function. J Hepatol 2002; 36 : 832–50. [Google Scholar]
  3. Sinal CJ, Tohkin M, Miyata M, et al. Targeted disruption of the nuclear receptor FXR/BAR impairs bile acid and lipid homeostasis. Cell 2000; 102 : 731–44. [Google Scholar]
  4. Xie W, Radominska-Pandya A, Shi Y, et al. An essential role for nuclear receptors SXR/PXR in detoxification of cholestatic bile acids. Proc Natl Acad Sci USA 2001; 98 : 3375–80. [Google Scholar]
  5. Xie W, Yeuh MF, Radominska-Pandya A, et al. Control of steroid, heme, and carcinogen metabolism by nuclear pregnane X receptor and constitutive androstane receptor. Proc Natl Acad Sci USA 2003; 100 : 4150–55. [Google Scholar]
  6. Peet DJ, Turley SD, Ma W, et al. Cholesterol and bile acid metabolism are impaired in mice lacking the nuclear oxysterol receptor LXR alpha. Cell 1998; 93 : 693–704. [Google Scholar]
  7. Jacquemin E, Hadchouel M. Genetic basis of progressive familial intrahepatic cholestasis. J Hepatol 1999; 31 : 377–81. [Google Scholar]
  8. Rosmorduc O, Hermelin B, Boelle PY, et al. ABCB4 gene mutation associated cholelithiasis in adults. Gastroenterology 2003; 125 : 452–9. [Google Scholar]
  9. Dray-Charier N, Paul A, Scoazec JY, et al. Expression of delta F508 cystic fibrosis transmembrane conductance regulator protein and related chloride transport properties in the gallbladder epithelium from cystic fibrosis patients. Hepatology 1999; 29 : 1624–34. [Google Scholar]
  10. Girodon E, Sternberg D, Chazouilleres O, et al. Cystic fibrosis transmembrane conductance regulator (CFTR) gene defects in patients with sclerosing cholangitis. J Hepatol 2002; 37 : 192–7. [Google Scholar]
  11. Fouassier L, Kinnman N, Lefevre B, et al. Contribution of mrp2 in alterations of canalicular bile formation by the endothelin antagonist bosentan. J Hepatol 2002; 37 : 184–91. [Google Scholar]
  12. Liu Y, Binz J, Numerick MJ, et al. Hepatoprotection by the farnesoid X receptor agonist GW4064 in rat models of intra- and extrahepatic cholestasis. J Clin Invest 2003; 112 : 1678–87. [Google Scholar]
  13. Lee J, Boyer JL. Molecular alterations in hepatocyte transport mechanisms in acquired cholestatic liver disorders. Semin Liver Dis 2000; 20 : 373–84. [Google Scholar]
  14. Lee J, Azzaroli F, Wang L, et al. Adaptive regulation of bile salt transporters in kidney and liver in obstructive cholestasis in the rat. Gastroenterology 2001; 121 : 1473–84. [Google Scholar]
  15. Kojima H, Nies AT, Konig J, et al. Changes in the expression and localization of hepatocellular transporters and radixin in primary biliary cirrhosis. J Hepatol 2003; 39 : 3702–5. [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.